Should we test the prothrombin time in anticoagulated epistaxis patients?

Por Soyka, Michael B., Holzmann, David
Publicado em 2013

Mechanisms of allergen-specific immunotherapy

Por Fujita, Hiroyuki, Soyka, Michael B, Akdis, Mübeccel, Akdis, Cezmi A
Publicado em 2012

Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia

Por Kovacs-Sipos, Evelin, Holzmann, David, Scherer, Thomas, Soyka, Michael B
Publicado no BMJ Case Rep (2017)

THREAT helps to identify epistaxis patients requiring blood transfusions

Por Murer, Karin, Ahmad, Nader, Roth, Beatrice A, Holzmann, David, Soyka, Michael B
Publicado em 2013

The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses

Por Soyka, Michael B., Holzmann, David, Basinski, Tomasz M., Wawrzyniak, Marcin, Bannert, Christina, Bürgler, Simone, Akkoc, Tunc, Treis, Angela, Rückert, Beate, Akdis, Mübeccel, Akdis, Cezmi A., Eiwegger, Thomas
Publicado no PLoS One (2015)